Medtronic (MDT) Net Margin (2014 - 2026)

Medtronic has disclosed Net Margin across 13 years of filings, most recently posting 15.17% for Q3 2026.

• In Q3 2026, Net Margin rose 296.0% year-over-year to 15.17%; the TTM figure through Jul 2026 stood at 14.04% (up 33.0% YoY), while the FY2026 annual figure was 13.3%, down 69.0% from the prior year.
• Net Margin came in at 15.17% for Q3 2026 at Medtronic, up from 12.84% in the prior quarter.
• In the past five years, Net Margin ranged from a high of 19.1% in Q1 2022 to a low of 5.75% in Q4 2022.
• Average Net Margin over 5 years is 13.48%, with a median of 13.24% recorded in 2024.
• Year-over-year, Net Margin slumped 1104 bps in 2022 and surged 566 bps in 2023.
• Over 5 years, Net Margin stood at 5.75% in 2022, then jumped by 99 bps to 11.41% in 2023, then jumped by 33 bps to 15.21% in 2024, then advanced by 1 bps to 15.42% in 2025, then fell by 2 bps to 15.17% in 2026.
• Per Business Quant data, the three most recent Net Margin figures were 15.17% in Q3 2026, 12.84% in Q2 2026, and 12.75% in Q1 2026.